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The genetic causes of intellectual disability (ID) are heterogeneous and include both 
chromosomal and monogenic etiologies.  The X-chromosome is known to contain many ID-
related genes and males show a marked predominance for intellectual disability. Here we report 
two females with syndromic intellectual disability. The first individual was relatively mild in her 
presentation with mild-moderate intellectual disability, hydronephrosis and altered pigmentation 
along the lines of Blaschko without additional conge ital anomalies. A second female presented 
shortly after birth with dysmorphic facial features, post-axial polydactyly and, on follow-up 
assessment, demonstrated moderate intellectual disability.  Chromosomal studies for Individual 1 
identified an X-chromosome deletion due to a de novo pericentric inversion; the inversion 
breakpoint was associated with deletion of the 5’UTR of the USP9X, a gene which has been 
implicated in a syndromic intellectual disability affecting females. The second individual had a 
de novo frameshift mutation detected by whole-exome sequencing that was predicted to be 
deleterious, NM_001039590.2 (USP9X): c.4104_4105del (p.(Arg1368Serfs*2)).  
Haploinsufficiency of USP9X in females has been associated with ID and congenital 
malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, 
polydactyly, Dandy Walker malformation and hypoplastic corpus callosum. The extent of the 
congenital malformations observed in Individual 1 was less striking than Individual 2 and other 
individuals previously reported in the literature, and suggests that USP9X mutations in females 
can have a wider spectrum of presentation than previously appreciated.   
















Intellectual disability (ID) affects 1-2% of the poulation (Leonard and Wen 2002; Ropers 2010) 
and can be due to genetic and/or environmental causes. Approximately 20% of children with ID 
have a detectable cytogenetic alteration seen on chromosomal microarray (Miller et al. 2010). 
The individuals with ID attributable to the presenc of a copy-number variant (CNV) can be 
syndromic in their presentation. The deletions and duplications can encompass several genes, 
and the phenotype may be due to the actions of one or more genes present within the region.  
Intellectual disability can also be monogenic. For b th CNV-related and monogenic ID, there is a 
predominance of males due to the presence of critical genes for neurodevelopment on the X-
chromosome.  Males with hemizygous mutations in these X-linked genes tend to be more 
severely affected, with female carriers of X-linked mutations frequently being unaffected or 
demonstrating milder manifestations of disease.  Haemophilia A is the classic example where 
female carriers of X-linked mutations affecting F8 are relatively asymptomatic (Plug et al. 
2006).  
Missense mutations in USP9X are recognized to cause a non-syndromic intellectual disability in 
males (Homan et al. 2014).  However, in females, mutations in USP9X have been identified as 
responsible for a clinically recognizable intellectual disability syndrome that is associated with 
short stature, anal anomalies, polydactyly, heart defects, cleft palate and structural brain 
malformations (Brett et al. 2014; Reijnders et al. 2016). The mutations are typically loss of 
function in the females and the additional clinical findings are not present in males carrying 













phenotype appears quite different in females, particularly as females often present with 
congenital malformations which are not typically seen in males. 
 
Here we present two females with USP9X-related ID.  The first female individual has a deletion 
in the 5’UTR of USP9X due to a de novo X chromosome rearrangement.  Her mutation is not the 
typical loss of function type mutation in USP9X previously reported in females with syndromic 
ID associated with malformations (Reijnders et al. 2016). Her relatively milder presentation 
broadens the spectrum that can be associated with USP9X mutations in females, and suggests 
that mutations that are not clearly loss of function can still lead to syndromic ID in females. The 
second female shows a more typical presentation of the USP9X syndrome in females, due to a 
novel frameshift mutation. These two cases highlight the spectrum of the USP9X clinical 
presentation. 
2. Material and Methods 
Individual 1: A standard karyotype (G-banding) was performed as part of routine work-up at our 
center to assess for chromosomal rearrangements in amniocytes and parental samples for 
Individual 1.  A commercially available comparative g nomic hybridization array test 
comprising 400,000 oligonucleotide probes and single ucleotide polymorphisms (Baylor 
College of Medicine- Medical Genetics Laboratories, Houston, United States) was also 
performed on amniocytes after the karyotype results. The X-inactivation patterns for both 
Individual 1 and 2 was determined by assessing the methylation pattern of a polymorphic repeat 
locus containing a methylation-sensitive restriction enzyme (HpaII) site within the promoter 
region of the SLITRK4 gene at Xq27.3 using methylation-sensitive PCR (Bertelsen et al. 2011). 













were PCR amplified. The PCR products were analyzed on an ABI 3130 XL genetic analyzer 
(Applied Biosystems) and the X-inactivation ratios were calculated as previously described (Lau 
et al. 1997).  
Individual 2: This child was most recently assessed through the Undiagnosed Diseases Program-
Western Australia, a cross-disciplinary public health service informed by the Undiagnosed 
Diseases Program at the United States National Institutes of Health (Tifft and Adams 2014) and 
operating as part of the Undiagnosed Diseases Network International (Taruscio et al. 2015). 
After review at the clinical panel meeting, whole exome sequencing was initiated and clinical 
exome data was analysed, as reported previously (Baynam et al. 2016). 
3. Clinical presentation and results 
Individual 1: The healthy, 39 year old G5P2 mother of the firstemale presented to the Prenatal 
Genetics Clinic for evaluation of fetal renal pyelectasis and a single umbilical artery at 17 weeks 
gestation. Rapid aneuploidy detection (RAD) was performed with subsequent karyotype on 
amniocentesis. The RAD was normal, however the karyotype showed an apparent pericentric 
inversion on the X chromosome; 46, X,inv(X)(p11.4;q21).  Karyotypes performed on  parental 
cultured lymphocytes showed this was a de novo pericentric inversion in the fetus. As a result of 
the de novo chromosomal abnormality, a prenatal microarray was offered and showed a small 
loss of 0.326 Mb on the X chromosome, arr (hg19) Xp11.4 (40644087-40970033) x1, which 
deletes the 5’UTR of USP9X (Figure 1).  The pregnancy was otherwise unremarkable aside from 
maternal hypothyroidism for which the mother took L-thyroxine. There were no exposures to 
teratogens.  The baby was delivered by spontaneous vaginal delivery at 38 weeks and 5 days.  













There were no dysmorphic features or congenital malformations recorded at birth with the 
exception of the 2-vessel cord.  The prenatal diagnosis of pyelectasis prompted a renal 
ultrasound that showed bilateral grade 2 hydronephrosis with a normal voiding 
cystourethrogram.  
The child’s early life was unremarkable with the exc ption of a poor weight gain that responded 
well to formula supplementation.  During her assessment for poor growth, she was noted to have 
mild hypotonia and a head ultrasound showed prominent lateral, third and fourth ventricles. A 
subsequent MRI revealed prominant extra-axial spaces but no cortical malformation (Figure 2).  
At 6 months of age she was noted to have hyper and hypopigmented streaks following the lines 
of Blaschko on her torso and back.  There was no hist ry of intellectual disability, developmental 
delays or seizures in her family. There was no history of consanguinity. 
The child presented again to the Medical Genetics Clinic at 10 months of age for developmental 
delay. At that time her head circumference was 43 cm (10th percentile) with a weight of 6.4kg 
(0.1-3rd percentile) and a length of 67cm (3rd percentile).  She was described as non-dysmorphic. 
A Woods lamp examination showed lines of Blaschko to her torso. 
A follow-up assessment at 3 years of age showed a well appearing female without striking 
dysmorphisms. There were no health concerns with the exception of delays in her development.  
Her first independent steps were at 2 years and 9 months of age.  Her first single words were at 2 
years of age. At age 3 years of age she had 3 to 5 single words only with no short phrases. There 
was no history of regression and no abnormal movements or seizures. A review of systems was 
unremarkable.  Her height was 92cm (10th percentile), weight was 12.1kg (5th percentile), and 













a broad forehead. Palpebral fissures were not up- or down slanted.  Ears had normal structure, 
attached lobules, and were not posteriorly rotated or low set. Palate and uvula were normally 
formed although her mouth was down-turned. She had dental caries and widely spaced teeth. 
While she was not considered dysmorphic, her teeth and down-turned mouth did give her a 
distinctive appearance.  She was proportionate with no asymmetry in her face, chest or limbs. 
Her spine was straight with no sacral dimple.  There was no hypertrichosis. There was 
hypermobility in her small joints, her hands and feet were slender and there was 
hyperpigmentation along the lines of Blaschko. The remainder of her examination was 
unremarkable. 
X-inactivation studies were performed for individual 1 after review of her microdeletion 
indicated that the recently described USP9X gene was impacted. These studies showed a 
preferential skewing of 80:20 of the X-chromosome from lymphocytes. 
Indvidual 2: The second individual was born to a healthy 37 year old G1P0 mother. The first 
trimester screen was high-risk  (1/130) for Trisomy 21 and an amniocentesis was performed with 
a normal G-banded karyotype at a 550 band level. The delivery was induced for growth 
deceleration. She was born at 38 weeks gestation and here Apgar scores were 6 at 1 minute and 9 
at 5 minutes. Birthweight was 2.5 kg (10th percentile), length was 47.5 cm (25th percentile) and 
head circumference was 32 cm (10th percentile). At birth she was found to have a two-vessel 
cord, post-axial polydactyly (non-articulated tissue on the right hand), a prominent facial 
hemagioma and she was dyspneic.  An abdominal ultrasound at 8 days of age was normal. An 
echocardiogram showed dilated cardiomyopathy with pulmonary hypertension that resolved 













mild to moderate dilatation of the third and fourth ventricles with bowing of the corpus callosum 
(Figure 3).  A chromosomal microarray at 9 years of age was normal. 
During follow-up assessments she was noted to have recurrent ear infections, high-frequency 
hearing loss, mild myopia, laryngomalacia and global developmental delay.  Her first 
independent steps were at 4 years.  At 9 years of age she had single words and for the most part 
communicated by sign language. Her receptive speech x eeded her expressive speech. There 
was no history of regression. 
At 9 years of age her height was 132cm (25th percentile), weight was  24.6 kg (10th percentile), 
and head circumference was 55cm cm (98th percentile).  She had a tall, broad forehead. She had 
a marked facial hemangiomata to her glabellum and forehead.  Palpebral fissures appeared short 
(not measured) and there was a wide inner canthal dist nce. She had a wide, flat nasal root with 
flared nares. Her philtrum was long, with a tented upper lip and a thick lower lip vermillion. Her 
dentition was crowded and her palate was high arched with no bifid uvula.  She had midfacial 
flattening and micro-retroganthia.  Her ears were low set and posteriorly rotated with attached 
lobules. She had facial asymmetry, and asymmetric pubertal development with a breast bud on 
the left and axillary hair on the right. Limbs were symmetric and proportionate. She had a 
thoracic scoliosis and a pectus excavatum. She had a s ndal gap between first and second toes, 
mild 2,3 cutaneous toe syndactyly and long fingers and toes.  There was no hypertrichosis. The 
remainder of her examination was unremarkable. Her facial features over time are illustrated in 
Figure 3.  
WES identified a frameshift mutation detected that w s predicted to be deleterious, 













performed and showed the mutation was de novo.  The mutation has not been previously seen in 
ExAc or ClinVar databases. No loss of function mutations have been reported in the ExAC 
browser database.  X-inactivation studies of lymphocytes from Individual 2 showed no evidence 
of significant, or preferential skewing of the X chromosome. The frameshift mutation and the 
chromosomal deletion observed in Individual 1 were submitted to the ClinVar database 
(SUB2523087). 
4. Discussion 
A recognizable, syndromic form of ID has been recently described specifically in 17 female 
patients with loss of function mutations in USP9X (Reijnders et al. 2016).  In addition to ID, the 
syndrome includes congenital anomalies such as choanal atresia, cleft palate, polydactyly, anal 
atresia, Dandy-Walker malformation as well as a history of thyroid disease, recurrent infections 
and hearing loss (Reijnders et al. 2016) (Table 1). Here we report two females with ID due to 
novel mutations in USP9X.  Both mutations in these children were de novo and have not been 
previously reported.  The first individual was a 3 year old female child with intellectual disability 
and pigmentary abnormalities. She was not overtly dysmorphic and has a relatively milder 
phenotype than those individuals previously reported, with absence of obvious facial 
dysmorphisms and other congenital anomalies (Table 1) (Reijnders et al. 2016).   However, the 
pigmentation abnormalities along the lines of Blaschko and hydronephrosis observed this patient 
were also observed in the large reported cohort (Reijnders et al. 2016).  Of note, her mutation 
comprises a deletion of the 5’UTR of the USP9X gene and, as such, is not clear if this is a 
complete loss of function mutation. The second individual was more typically dysmorphic, and 
thus more similar to previously reported  individuals (Figure 3). Facial features in individual 2 













flat nasal bridge, wide inner canthus, short palpebral fissures, flared nares, a long philtrum and 
low set posteriorly rotated ears. In addition, indivi ual 2  also presented with post-axial 
polydactyly, ventriculomegaly, and recurrent respirato y tract infections, similar to previously 
reported females with loss of function mutations. The clinical findings in these two new cases 
highlights that mutation of USP9X can be associated with a broader phenotypic spectrum in 
females than previously described.  
The female patients reported by Reijnders et al. that defined this new intellectual 
disability syndrome all had USP9X loss of function due to stop gain, frameshift and splice-site 
mutations, in addition to intragenic deletion and whole gene deletions. There was one missense 
mutation identified that was present in the catalytic domain that was predicted to be loss of 
function (Reijnders et al. 2016). Individual 1 presented here has an interrupted USP9X gene due 
to pericentric inversion resulting in deletion of the 5’UTR, and  individual 2 has a frameshift 
mutation, (USP9X): c.4104_4105del (p.(Arg1368Serfs*2)) predicted to be loss of function. 
Males have been reported with maternally inherited missense mutations in USP9X (Homan et al. 
2014). One male has been reported with a frameshift mutation in the last exon of USP9X, 
expected to escape nonsense mediated decay (Homan et al. 2014). However, no males have been 
reported with proven hemizygous loss-of-function mutation in USP9X, suggesting that loss of 
function in males is likely lethal, which is supported by male, and female, lethality in mice with 
of conditional loss-of-function of Usp9x -/- or Usp9x -/y in the mouse brain (Stegeman et al. 
2013). The heterozygous carrier females of the conditi al Usp9x +/- deletion in brain were 
normal at birth and lived into adulthood (Stegeman et al. 2013).  A milder phenotype was 
observed in female mice with Usp9x -/- deletions expressed in the telencephalon structures-only; 













corpus callosum (Stegeman et al. 2013). Interestingly, the reported male patients with missense 
mutations in this gene (Homan et al. 2014; Paemka et al. 2015) do not exhibit any of the 
congenital malformations described in females with loss of function mutations, although they do 
have intellectual disability, short stature and occasionally epilepsy (Paemka et al. 2015). 
Furthermore, these male patients typically inherit their missense mutation mutations from carrier 
mothers with no apparent features of disease (Homan et l. 2014). This dichotomy in mutation 
type and inheritance pattern is similar to that seen observed in individuals and families with 
DDX3X mutations. 
De novo heterozygous mutations in DDX3X in females cause a form of intellectual 
disability characterized by an associated movement disorder, seizures and central nervous system 
abnormalities.  The de novo mutations identified in females, which include stop, frameshift and 
missense changes, are all predicted to be loss of function based on zebrafish studies (Snijders 
Blok et al. 2015). However, like USP9X, missense mutations in DDX3X have also been 
identified in males as a cause of intellectual disability (Snijders Blok et al. 2015) .  In these 
families, carrier females of the missense mutations were not affected with ID, and further, 
missense DDX3X mutations found in males have failed to demonstrate loss of function in the 
zebrafish model (Snijders Blok et al. 2015). The mechanisms of action of these milder missense 
mutations is still unclear but is speculated to be related to the dosage sensitivity of the DDX3X 
gene. 
In individual 1, it is not clear if the 5’UTR deletion of USP9X truly causes loss of 
function of the gene. Deletions of the 5’UTR may not ecessarily lead to complete loss of 
function, although this may lead to reduced amount f protein due to impact on the gene 













that some functional gene product can still be produce  from this allele.  Unfortunately, no cell 
lines are available to examine protein expression of USP9X in individual 1.  Residual USP9X 
protein expression from the affected allele may be the contributing factor to this patient’s milder 
presentation, particularly if USP9X is dosage sensitive as consistent with mouse experiments 
(Stegeman et al. 2013) and as DDX3X is suggested to be (Snijders Blok et al. 2015). 
The milder phenotype in individual 1  could also be du , in part, to favourable X-inactivation, 
where the unaffected X chromosome is preferentially expressed. DDX3X and USP9X are located 
in close proximity to one another at Xp11 and are both known to escape X-inactivation (Zhang et 
al. 2013). In some genes such as DDX3X this escape is not fully complete and is considere a 
partial X-inactivation (Reijnders et al. 2016). The pr sence of pigmentary changes along the 
lines of Blaschko, in some females, does suggest a degree of lionization (Happle 2006; Reijnders 
et al. 2016).  In other conditions where the relevant gene is known to escape X-inactivation, 
either partially or more completely, skewing may not fully rescue the disease phenotype if 
normal development requires biallelic expression. While not significant, preferential X-
inactivation (80:20) was seen in the “mild” first individual with the hyper-pigmentation along the 
lines of Blaschko.  In addition, three of five previously reported females with heterozgyous loss-
of-function mutations in USP9X tested for skewing were also found to be greater than 90% 
skewed (Reijnders et al. 2016). Skewing in blood lymphocytes does not so far appear to be 
correlated with the severity of symptoms, but this may not represent the relevant developmental 
stage or tissue specific effects of X-inactivation and skewing (Reijnders et al. 2016). It is 
possible that the relative extent of the escape from X-inactivation of the affected versus 
unaffected allele, and the extent of subsequent X-inact vation in the relevant tissues of the central 













In conclusion, we have reported a female with a de novo pericentric inversion that is associated 
with a 0.326 Mb deletion in the 5’ UTR of USP9X, and another female with a de novo frameshift 
mutation.   In contrast with the second individual, the first individual presented more mildly than 
other females described in the literature with USP9X-related ID. While she had some differences 
that were in keeping with other USP9X mutation affected females, such as hydronephrosis and 
pigmentation abnormalities, her presentation was milder with the relative absence of major 
congenital malformations, and we suggest that mutations in USP9X can have a wider spectrum 
of presentation in females than previously reported, Further identification and study of  male and 
female patients with varying types of USP9X mutations may improve our understanding of 
genotype-phenotype correlation, dosage and gender specific variability associated with this rare 
ID syndrome. 
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Figure 1. Title: Deletion of 5’ USP9X. Red arrows demarcate th  inversion breakpoints. The red 
horizontal bar represents the deletion. Blue rectangles represent exons of RefSeq genes within 
the region and the images was modified from UCSC Genome Browser, GRCh37/hg19 assembly 
(https://genome.ucsc.edu/index.html). 
 
Figure 2. Title: Images of brain, hands and feet of Individual 1. A- Axial single shot fast spin 
echo (SSFSE) of Case 1. Shows prominence of extra-aial spaces and lateral ventricles with 
otherwise normal structure and sulcal gyri. B-Coronal SSFSE views of Individual 1 showing 
normal structure and gyri of cortex and cerebellum. C, D shows hands and feet of case 1. Digits, 
nails and creases were described as normal though with hypermobility to small joints of hand 
and slender feet. 
 
Figure 3. Title: Images of Individual 2; A,C-D show broad forehead, prominent hemangioma, 
short palpebral fissures with a wide inner canthus. The nose has a flat nasal root, and a wide base 
with flared nares. Philtrum is long.  B-shows the low set, rotated helix with attached lobule. C-

















Table 1. Clinical features in females with USP9X mutations* 
Features Individual 1 Individual 2 Rejinders et al., 2016 
Intellectual disability Mild-moderate Moderate 17/1 
Prominent forehead No Yes n/a 
Low nasal bridge, prominent nose 
with flared alae n/asi and a broad 
n/asal base  
 
No Yes n/a 
Thin upper lip Yes Yes n/a 
Low set ears and posteriorly 
rotated ears 
No Yes n/a 
Attached lobules Yes Yes n/a 
Short stature No No 9/17 
Eye abnormalities No Myopia 10/17 
Choanal atresia No No 6/17 
Cleft palate/high arched 
palate/bifid uvula 
No Yes 5/17 
Dental abnormalities Caries Dental 
Crowding 
12/17 
Asymmetric hypomastia  No Yes 5/17 
Heart defect No Cardiomyopathy 7/16 
Urogenital abnormality Hydronephrosis  None 5/17 
Sacral dimple No No 5/17 













Post-axial polydactyly No Yes 9/17 
Abdomin/al wall abnormality No No 2/17 
Anal atresia No No 9/17 
Seizures No Yes 4/17 




Dandy Walker malformation No No 5/13 
Corpus callosum abnormalities No No 8/13 
Cerebellar hypoplasia No No 6/11 
Ventriculomegaly No Yes 8/11 
Thin brain stem No No 3/10 
Abnormal gyration pattern No No 5/10 
Hearing loss No Yes 11/17 
Pigmentary abnormality Lines of 
Blaschko 
present to torso 
No 11/17 
Hypertrichosis No No 5/17 
Limb length discrepancy No No 7/17 
Malignancy No No 2/17 
Recurrent infections No Yes 9/17 
Thyroid abnormality TSH and free T4 
in normal range 
TSH normal 6/17 
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